SCHEMBL4597637

SCHEMBL4597637

N=CCc1ncc[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8052261 0.83 ALOX15 (0.48)
SCHEMBL11317 0.79
SCHEMBL27611398 0.79
SCHEMBL1777427 0.79
SCHEMBL344880 0.79
SCHEMBL20746545 0.79
SCHEMBL3758953 0.79
Hydrochloric Acid SCHEMBL3806550 0.77
SCHEMBL10484488 0.77
Water SCHEMBL28393920 0.77 ALOX15 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1351979-B1 REGULATED ACTIVATION OF CELL-MEMBRANE RECEPTORS BY METAL-CHELATING AGONISTS SMITHKLINE BEECHAM CORP (US) 2008-01-16 EP claimed
EP-1032387-B1 NOVEL METAL COMPLEXES SMITHKLINE BEECHAM CORP (US) 2007-03-07 EP claimed
EP-1039906-B1 METAL COMPLEXES WITH ANTIBACTERIAN AND FUNGICIDAL EFFECTS SMITHKLINE BEECHAM CORP (US) 2008-02-27 EP disclosed
EP-1351979-B1 REGULATED ACTIVATION OF CELL-MEMBRANE RECEPTORS BY METAL-CHELATING AGONISTS SMITHKLINE BEECHAM CORP (US) 2008-01-16 EP disclosed
EP-1032387-B1 NOVEL METAL COMPLEXES SMITHKLINE BEECHAM CORP (US) 2007-03-07 EP disclosed
EP-1351979-A4 REGULATED ACTIVATION OF CELL-MEMBRANE RECEPTORS BY METAL-CHELATING AGONISTS SMITHKLINE BEECHAM CORP (US) 2005-04-27 EP disclosed
US-20040053299-A1 Regulated activation of cell-membrane receptors by metal-chelating agonists SMITHKLINE BEECHAM CORPORATION 2004-03-18 US disclosed
EP-1032387-A4 NOVEL METAL COMPLEXES SMITHKLINE BEECHAM CORP (US) 2004-02-11 EP disclosed
EP-1039906-A4 NOVEL METAL COMPLEXES SMITHKLINE BEECHAM CORP (US) 2004-02-11 EP disclosed
EP-1351979-A1 REGULATED ACTIVATION OF CELL-MEMBRANE RECEPTORS BY METAL-CHELATING AGONISTS SmithKline Beecham Corporation (US) 2003-10-15 EP disclosed
US-20030013697-A1 Agonizing dimeric cell-surface receptors with a receptor binding moiety and chelating metal SMITHKLINE BEECHAM CORPORATION AND LIGAND PHARMACEUTICALS 2003-01-16 US disclosed
US-6413952-B1 FORMING METAL-CHELATE COMPOUND SMITHKLINE BEECHAM CORPORATION 2002-07-02 US disclosed
US-6280959-B1 Zinc chelated cell surface receptor ligands for use as agonist of dimeric cell surface receptors; for example, 2-bis(2,5-bis(2-benzimidazolylimino)-3A,6A-diphenyl-1,2,3,3a, 4,5,6,6a-octahydroimidazo(4,5-d)imidazole-N,N')-zinc(II) SMITHKLINE BEECHAM CORPORATION 2001-08-28 US disclosed
US-20010016568-A1 NOVEL METAL COMPLEXES SMITHKLINE BEECHAM CORPORATION 2001-08-23 US disclosed
US-20010014454-A1 NOVEL METAL COMPLEXES NOVARTIS AG (CH) 2001-08-16 US disclosed
US-6211200-B1 ADMINISTERING ZINC CHELATED IMIDAZO(4,5-D)IMIDAZOLE COMPOUNDS AS GRANULOCYTE COLONY STIMULATING FACTOR AGONISTS SMITHKLINE BEECHAM CORPORATION 2001-04-03 US disclosed
EP-1039906-A1 NOVEL METAL COMPLEXES SMITHKLINE BEECHAM CORPORATION (US) 2000-10-04 EP disclosed
EP-1032387-A1 NOVEL METAL COMPLEXES SMITHKLINE BEECHAM CORPORATION (US) 2000-09-06 EP disclosed
WO-1999022733-A1 NOVEL METAL COMPLEXES SMITHKLINE BEECHAM CORPORATION (US) 1999-05-14 WO disclosed
WO-1999022732-A1 NOVEL METAL COMPLEXES SMITHKLINE BEECHAM CORPORATION (US) 1999-05-14 WO disclosed